Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview


« Back to Dashboard
Nicotine Polacrilex is a drug marketed by Actavis Labs Ny Inc, Perrigo R And D, Watson Labs, Ivax Sub Teva Pharms, and Perrigo. and is included in thirty-two NDAs. It is available from thirty-nine suppliers.

The generic ingredient in NICOTINE POLACRILEX is nicotine polacrilex. There are twenty-nine drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.

Summary for Tradename: NICOTINE POLACRILEX

Suppliers / Packagers: see list39
Drug Prices: :see details

Clinical Trials for: NICOTINE POLACRILEX

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo R And D
nicotine polacrilex
TROCHE/LOZENGE;ORAL203690-001Oct 9, 2012OTCNo
nicotine polacrilex
GUM, CHEWING;BUCCAL076778-001Sep 16, 2004OTCNo
Perrigo R And D
nicotine polacrilex
TROCHE/LOZENGE;ORAL203690-002Oct 9, 2012OTCNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.